Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4100 participants.
Also called NCT06871228
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 4,100 participants
- Sponsor
- Registry
-
NCT06871228
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06871228. Randomized; single masking; primary purpose treatment. Start 2025-08-05 (actual); primary completion 2029-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
- Acronym
- DIAMOND-AF
- Condition
- Atrial Fibrillation (AF)
- Intervention (Drug)
- NOAC discontinuation
- Intervention (Drug)
- NOAC continuation
- Intervention (Device)
- Smartwatch single-lead ECG (electrocardiogram) monitoring
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct06871228- Content hash
27fdbcf2a8da77df1e395d3ab765d0d0f146bc5fd563b6ad9d06f00867f945c9